Form D · Biotechnology
SynerGene Therapeutics, Inc.
Potomac, MD · CIK 0001091006
Offering snapshot reported Dec 16, 2014 · SEC filing
- Reported sold
- $6.37M Offering amount: $7.15M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $33K Reported outside-investor minimum
- First sale
- Dec 3, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2014 | Initial | $6,368,989 | No comparison | 10 | SEC filing |
| Jun 10, 2014 | Initial | $860,000 | No comparison | 6 | SEC filing |
| Apr 2, 2014 | Initial | $2,381,000 | No comparison | 38 | SEC filing |
| Aug 23, 2012 | Amendment | $1,127,000 | $325,000vs Jul 31, 2012 | 16 | SEC filing |
| Jul 31, 2012 | Initial | $802,000 | No comparison | 14 | SEC filing |
| Sep 14, 2011 | Initial | $1,570,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-230200
Source: Form D, filed Dec 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Chang | Director |
| James Hsu | Director |
| Maria Magdalena Ruiz | Executive |
| Raj Shah | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9812 Falls Road Suite 114
Potomac, MD, 20854
Potomac, MD, 20854